menu
    • menu

    Company profile for MinervaX

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MinervaX announces completion of 47.4 mEUR financing with Sanofi Ventures, Wellington Partners, Adjuvant Capital and Industrifonden joining existing investors Novo Holding's REPAIR Impact Fund, Sunstone Life Science Ventures and LF Investment. Proceeds will be used to advance the Company's GBS vaccine through Phase II and preparation for Phase III. Minervax ApS is a biotechnology company based out of 28 Vedbendvej, Hellerup, C...
    MinervaX announces completion of 47.4 mEUR financing with Sanofi Ventures, Wellington Partners, Adjuvant Capital and Industrifonden joining existing investors Novo Holding's REPAIR Impact Fund, Sunstone Life Science Ventures and LF Investment. Proceeds will be used to advance the Company's GBS vaccine through Phase II and preparation for Phase III. Minervax ApS is a biotechnology company based out of 28 Vedbendvej, Hellerup, Capital Region of Denmark, Denmark. MinervaX is pursuing the development of a novel vaccine candidate against Group B Streptococci.The National Institute of Health of the US has identified prevention of GBS in newborns.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MinervaXDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Ole Maaløes Vej 3 DK-2200 Copenhagen N Denmark
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.minervax.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Minervax Bolsters Leadership Team For Maternal GBS Vaccine Trial
    Minervax Bolsters Leadership Team For Maternal GBS Vaccine Trial

    15 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-15/minervax-strengthens-executive-leadership-team-with-two-strategic-appointments-as-it-advances-its-maternal-gbs-vaccine-towards-pivotal-trial-initiatio

    PHARMIWEB
    15 Apr 2026
    Share Share
    Veronica Gambillara Fonck Appointed Chair of MinervaX
    Veronica Gambillara Fonck Appointed Chair of MinervaX

    14 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biotech-entrepreneur-veronica-gambillara-fonck-appointed-chair-of-minervax-302305997.html

    PR NEWSWIRE
    14 Nov 2024
    Share Share
    MinervaX, Wacker Biotech Enter GBS Vax Pact
    MinervaX, Wacker Biotech Enter GBS Vax Pact

    17 Sep 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-09-17/minervax-wacker-biotech-enter-gbs-vax-pact/

    CONTRACT PHARMA
    17 Sep 2024
    Share Share
    MinervaX And Wacker Biotech Partner For Group B Streptococcus Vaccine
    MinervaX And Wacker Biotech Partner For Group B Streptococcus Vaccine

    16 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/minervax-and-wacker-biotech-announce-manufacturing-collaboration-for-prophylactic-vaccine-targeting-group-b-streptococcus-302249275.html

    PR NEWSWIRE
    16 Sep 2024
    Share Share
    MinervaX Raises EUR 54M in Upsized Financing to Advance Group B Streptococcus
    MinervaX Raises EUR 54M in Upsized Financing to Advance Group B Streptococcus

    11 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/minervax-raises-eur-54m-in-upsized-financing-to-advance-the-development-of-its-maternal-vaccine-against-group-b-streptococcus-301952361.html

    PR NEWSWIRE
    11 Oct 2023
    Share Share
    MinervaX raises €54M as it aims to move group B Streptococcus vaccine into PhIII
    MinervaX raises €54M as it aims to move group B Streptococcus vaccine into PhIII

    11 Oct 2023

    // Katherine Lewin ENDPTS

    https://endpts.com/minervax-raises-e54m-in-upsized-financing-round-to-progress-group-b-streptococcus-vaccine/

    Katherine Lewin ENDPTS
    11 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search